|
Volumn 76, Issue 2, 1998, Pages 135-141
|
Priority during a meningitis epidemic: Vaccination or treatment?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE CONTROL;
EPIDEMIC;
INFECTIOUS DISEASE;
VACCINATION;
ARTICLE;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
HUMAN;
INFECTION PREVENTION;
MAJOR CLINICAL STUDY;
MENINGITIS;
NEISSERIA MENINGITIDIS;
NIGERIA;
VACCINATION;
ANTI-BACTERIAL AGENTS;
CHLORAMPHENICOL;
COST-BENEFIT ANALYSIS;
DISEASE OUTBREAKS;
HEALTH PRIORITIES;
HUMANS;
INCIDENCE;
MENINGITIS, MENINGOCOCCAL;
NEISSERIA MENINGITIDIS;
NIGERIA;
VACCINATION;
NIGERIA;
|
EID: 0031777690
PISSN: 00429686
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (31)
|
References (11)
|